CJC-1295 + Ipamorelin

10mg

CJC-1295 + Ipamorelin is a combination peptide blend widely studied in growth hormone secretagogue research. CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) with enhanced stability due to Drug Affinity Complex (DAC) technology, while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, they have been investigated for synergistic effects on pulsatile growth hormone release, body composition modulation, and recovery mechanisms in preclinical research models. The 10mg formulation is provided for in vitro research and scientific investigation.